Treatment of generalized vitilogo in children with narrow-band (TL-01) UVB radiation therapy

Journal of the American Academy of Dermatology

Volumn 42, Issue 2 I, 2000, Pages 245-253

  Njoo, M D ^a,b,c   Bos, J D ^b   Westerhof, W ^a,b  

^a Dutch Institute for Pigmentary Disorders (SNIP)   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION; VITILIGO; PHOTOTHERAPY;

CHILD; FEMALE; HUMANS; MALE; PATIENT COMPLIANCE; QUALITY OF LIFE; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; VITILIGO;

EID: 0034132870     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(00)90133-6     Document Type: Article

References (40)

1. Nordlund JJ, Ortonne JP. Vitiligo vulgaris. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP, editors. The pigmentary system: physiology and pathophysiology. New York: Oxford University Press; 1998. p. 513-51.
2. Westerhof W, Bolhaar B, Menke HE, Harper JI. Resultaten van een enquête onder vitiligo patienten. Ned Tijdschr Dermatol Venereol 1996;6:100-5.
3. Halder RM, Grimes PE, Cowan CA, Enterline JA, Chakrabarti SG, Kenney JA Jr. Childhood vitiligo. J Am Acad Dermatol 1987;16: 948-54.
4. Jaisankar TJ, Baruah MC, Garg BR. Vitiligo in children. Int J Dermatol 1992;31:621-3.
5. Porter J, Hill-Beuf A, Nordlund JJ, Lerner AB. Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen Hosp Psychiatry 1979;1:73-7.
6. Hill-Beuf A, Porter JDR. Children coping with impaired appearance: social and psychologic influences. Gen Hosp Psychiatry 1984;6:294-301.
7. Lacour J-P. Vitiligo in children: a serious psychological repercussion, in spite of its harmlessness. Rev Prat Med Gen 1994;8:37-44.
8. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation versus topical psoralen plus UVA. Arch Dermatol 1997;133:1525-8.
9. Pathak MA, Fitzpatrick TB. Preventive treatment of sunburn, dermatoheliosis and skin cancer with sun-protective agents. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, editors. Dermatology in general medicine. 4th ed. New York: McGraw-Hill; 1993. p. 1689-717.
10. Njoo MD, Das PK, Bos JD, Westerhof WW. Association of the Koebner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol 1999;135: 407-13.
11. Lewis-Jones MS, Finlay AY. The children's dermatology life quality index (CDLQI): initial validation and practical use. Br J Dermatol 1995;132:942-9.
12. Finlay AY. Quality of life measurement in dermatology: a practical guide. Br J Dermatol 1997;136:305-14.
13. Altman DG, editor. Practical statistics for medical research. London: Chapman and Hall; 1997.
14. Gardner ML, Altman DG, editors. Statistics in medicine. London: British Medical Journal; 1989.
15. Sehgal VN. Oral trimethylpsoralen in vitiligo in children: a preliminary report. Br J Dermatol 1971;85:454-6.
16. Ruiz Maldonado R, Tamayo Sanchez L. 4-5-8 Trimethylpsoralen in vitiligo: controlled study of its therapeutic and toxic effect in children. Actas Dermo Sif 1975;66:513-26.
17. Theodoridis A, Tsambaos D, Sivenas C, Capetanakis J. Oral trimethylpsoralen in the treatment of vitiligo. Acta Derm Venereol (Stockh) 1976;56:253-6.
18. Drake LA, Dinehart SM, Farmer ER, Holtz RW, Graham GF, Hordinsky MK, et al. Guidelines of care for vitiligo. J Am Acad Dermatol 1996;35:620-6.
19. Antoniou C, Katsambas A. Guidelines for the treatment of vitiligo. Drugs 1992;43:490-8.
20. Atherton DJ, Cohen BL, Knobler E, Garzon M, Morelli JG, Tay YK, et al. Phototherapy for children, special symposium. Pediatr Dermatol 1996;13:415-26.
21. Tay YK, Morelli JG, Weston WL Experience with UVB phototherapy in children. Pediatr Dermatol 1996;13:406-9.
22. Schulpis CH, Antoniou C, Michas T, Strarigos J. Phenylalanine plus ultraviolet light: preliminary report of a promising treatment for childhood vitiligo. Pediatr Dermatol 1989;6:332-5.
23. Pasricha JS, Khaitan BK. Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease. Int J Dermatol 1993;32:753-7.
24. Grimes PE, Kelly AP, Cline DJ, Nordlund JJ, Jareatt MT, Rogers M, et al. Management of vitiligo in children. Symposium. Pediatr Dermatol 1986;3:498-510.
25. Grimes PE. Vitiligo: an overview of therapeutic approaches. Dermatol Clin 1993;11:325-38.
26. Khalid M, Mujtaba G, Haroon TS. Comparison of 0.05% clobetasol propionate cream and topical PUVASOL in childhood vitiligo. Int J Dermatol 1995;34:203-5.
27. Köster W, Wiskemann A. Phototherapy with UV-B in vitiligo. Z Hautkr 1990;65:1022-4.
28. Pathak MA, Mosher DB, Fitzpatrick TB. Safety and therapeutic effectiveness of 8-methoxypsoralen, 4,5,8-trimethylpsoralen and psoralen in vitiligo. Natl Cancer Inst Monogr 1984;66:165-73.
29. Norris DA, Horikawa T, Morelli JG. Melanocyte destruction and repopulation in vitiligo. Pigment Cell Res 1994;7:193-203.
30. Fitzpatrick TB. Mechanisms of phototherapy in vitiligo. Arch Dermatol 1997;133:1591-2.
31. Cui J, Shen LY, Wang GC. Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol 1991;97:410-6.
32. Al-Aboosi MM, Ajam ZA. Oral photochemotherapy in vitiligo: follow-up, patient compliance. Int J Dermatol 1995;34:206-8.
33. Stern RS, Lange R, Members of the photochemotherapy follow-up study: non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol 1988;91:120-4.
34. Stern RS, Laird N. The carcinogenic risk of treatment for severe psoriasis. Cancer 1994;73:2759-64.
35. Sterenborg HJCM, van Weelden H, van der Leun JC. The dose-response relationship for tumorigenesis by UV radiation in the region 311-312 nm. J Photochem Photobiol B 1988;2:179-94.
36. Slaper H, Schothorst AA, van der Leun JC. Risk evaluation of UVB therapy for psoriasis: comparison of calculated risk for UVB therapy and observed risk in PUVA treated patients. Photodermatol 1986;3:271-83.
37. Stern RS, Members of the photochemotherapy follow-up study. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. N Engl J Med 1990;322:1093-7.
38. Lewis-Jones MS, Lawson V, Hill G, Reid P, Owens G, Finlay AY. Monitoring childhood skin disease handicap [abstract]. Br J Dermatol 1996;135(Suppl 47):52.
39. Kent G, Al'Abadie M. Psychologic effects of vitiligo: a critical incidence analysis. J Am Acad Dermatol 1996;35:895-8.
40. Porter JR, Hill-Beuf A, Lerner A, Nordlund J. Psychosocial effect of vitiligo: a comparison of vitiligo patients with "normal" control subjects, with psoriasis patients, and with patients with other pigmentary disorders. J Am Acad Dermatol 1986;15:220-4.